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Purpose: FDG uptake in the primary tumors and malignant lymph 
nodes of NSCLC has been reported to be mediated by glucose trans-
porter type 1 (glut-1). The level of FDG uptake in primary tumors may 
affect the likelihood of malignant involvement in the loco-regional 
lymph nodes. Therefore, we investigated the correlation of FDG uptake 
and glut-1 expression between primary tumors and loco-regional lymph 
nodes of NSCLC.
Methods: One hundred twenty-six NSCLC patients (male:fe-
male=103:23, age=65±9.7y) who had underwent curative resec-
tions and loco-regional lymph node dissections within 4 weeks after 
FDG-PET study were enrolled. Maximum standardized uptake values 
(maxSUV) on PET and glut-1 expression percentages on surgical speci-
mens were measured and compared between primary tumors and FDG 
uptake positive loco-regional lymph nodes. 
Results: After excluding the peribronchial lymph nodes directly 
invaded by primary tumors and the benign lymph nodes with no FDG 
uptake, 126 primary tumors and 196 loco-regional lymph nodes (52 
malignant and 144 benign) were analyzed. Fifty-two malignant lymph 
nodes were compared with 37 primary tumors. There were signiﬁcantly 
high correlations of maxSUV (r=0.6399, p<0.0001) and percentage of 
glut-1 expression (n=15, r=0.8193, p=0.0002) between primary tumors 
and malignant lymph nodes. Linear regression equation between 
maxSUV of malignant lymph nodes (Y) and maxSUV of primary 
tumors (X) was expressed as Y = 0.6891 + 0.4679 X. To the contrary, 
144 benign lymph nodes were not correlated with 75 primary tumors in 
terms of maxSUV (r=-0.0125, p=0.8831) and glut-1 (n=19, r=0.3876, 
p=0.1010) expression. 
Conclusions: Primary tumors of NSCLC had high correlations of FDG 
uptake and glut-1 expression with malignant lymph nodes but not with 
benign lymph nodes. Mediastinal lymph node staging of NSCLC by 
FDG-PET may be improved by considering the correlation of FDG 
uptake and glut-1 expression between primary tumors and malignant 
lymph nodes
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Background: Extrapleural pneumonectomy (EPP) in MPM may be 
conﬁned with both morbidity and mortality and careful preoperative 
staging identifying respectable patients is important. Staging is difﬁcult 
and the accuracy of preoperative CT-scan, 18F-FDG-PET-CT-scan 
fused imaging (PET-CT), and mediastinoscopy is unclear. The objec-
tives were to compare these staging techniques to each other and to 
surgical-pathological ﬁndings.
Methods: Patients had epithelial subtype MPM, age ≤ 70 years, and 
lung function test allowing pneumonectomy. Preoperative staging after 
3-6 courses of induction chemotherapy included conventional CT-scan, 
PET-CT, and mediastinoscopy. Surgical-pathological ﬁndings were 
compared to preoperative ﬁndings.
Results: 42 consecutive patients were without T4 or M on CT-scan. 
PET-CT showed inoperability in 12 patients (29%) due to T4 (7 
patients) and M1 (7 pts). Among 30 patients with subsequent mediasti-
noscopy, including 10 with N2/N3 on PET-CT, N2 were histologically 
veriﬁed in 6 (14%). Among 24 resected patients, T4 occurred in 2 
patients (8%), and N2 in 4 (17%), all being PET-CT negative. PET-CT 
accuracy of T4 and N2/N3 compared to combined histological results 
of mediastinoscopy and EPP showed sensitivity, speciﬁcity, pos. pre-
dictive value, neg. predictive value, and pos. and neg. likelihood ratios 
of 78% and 50%, 100% and 75%, 100% and 50%, 94% and 75%, not 
applicable and 5.0, and 0.22 and 0.67, respectively. 
Conclusions: Non-curative surgery is avoided in 29% out of 42 MPM 
patients by preoperative PET-CT and in further 14% by mediastinosco-
py. Even though both procedures are valuable, there are false negative 
ﬁndings with both, urging for even more accurate staging procedures.
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Purpose: to determine prospectively whether the standardized uptake 
value (SUV) of ﬂuorodeoxyglucose uptake by positron emission to-
mography (FDG-PET) could be a prognostic factor for refractory non-
small-cell lung cancer NSCLC treated with erlotinib. To prospectively 
evaluate the use of (FDG-PET) on response evaluation to erlotinib.
Patients and Methods: Patients with histologically proven NSCLC 
pretreated with chemotherapy, undergo palliative erlotinib 150 mg/die 
were eligible for this study. Patients were evaluated by FDG-PET 
before erlotinib and after 45 days of therapy: A decrease of 20% or 
more in tumor FDG uptake as measured by standardized uptake value 
(SUV) was deﬁned as a metabolic response. Radiologic response was 
evaluated by CT scan according to RECIST criteria after 60 days of 
treatment .
Results: From September 2006 to February 2007, 16 patients have 
been included in this study. Patients characteristics were as follows: 
